In MYC-driven B-cell lymphomas, MYC enhances the translation of glutaminase (GLS), which converts glutamine (Gln) into glutamate, which is then further metabolized in the TCA cycle, providing intermediates for energy synthesis (ATP), a fundamental process for the high proliferation rate of these cancerous cells [14]. Here, GLS is linked to B-cell non-Hodgkin lymphoma.